Strategies to Genetically Modulate Dendritic Cells to Potentiate Anti-Tumor Responses in Hematologic Malignancies

Dendritic cell (DC) vaccination has been investigated as a potential strategy to target hematologic malignancies, while generating sustained immunological responses to control potential future relapse. Nonetheless, few clinical trials have shown robust long-term efficacy. It has been suggested that...

Descripción completa

Detalles Bibliográficos
Autores principales: Cornel, Annelisa M., van Til, Niek P., Boelens, Jaap Jan, Nierkens, Stefan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2018
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5968097/
https://www.ncbi.nlm.nih.gov/pubmed/29867960
http://dx.doi.org/10.3389/fimmu.2018.00982

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5968097/
https://www.ncbi.nlm.nih.gov/pubmed/29867960
http://dx.doi.org/10.3389/fimmu.2018.00982

Ejemplares similares